My Medicine - The Pretty Reckless | Cover by Louna Maroun
Stay in school and don #39;t do candy. HELP ME TWEET THIS: http://clicktotweet.com/dXbb2 FREE MP3: http://soundcloud.com/loopylady11/lounamymedicine BLOOPERS: ht...
By: Loopylady11
Excerpt from:
My Medicine - The Pretty Reckless | Cover by Louna Maroun - Video
Newswise Hospital for Special Surgery (HSS), the nations top hospital for orthopedics, will host Current Concepts in Sports Medicine, an educational symposium to discuss how to identify, prevent and treat articular cartilage and hip/pelvis injuries, as well as injuries common to the throwing and multisport athlete.
The two-day symposium co-directed by Frank Cordasco, M.D., sports medicine orthopedic surgeon; and John Cavanaugh, P.T., MEd, ATC, SCS, features the expertise of HSSs Sports Medicine and Shoulder Service and Rehabilitation and Performance staff. It is specifically designed for physician assistants, physical therapists, physical therapist assistants, athletic trainers, coaches, nurse practitioners and other healthcare professionals to learn how to properly manage sports-related medical issues and hear about the latest treatments advances from HSS experts.
Physicians and physical therapists from Hospital for Special Surgery have the distinction of being the team physicians for 17 professional and college teams, and the Sports Medicine and Shoulder Service has trained more than 100 of the sports medicine leaders in institutions all over the world.
HSS continues to grow and advance medicine with pioneering surgical treatments techniques, said Dr. Cordasco. Our staff is uniquely positioned to share information with local, regional and national audiences on how were developing and restoring mobility to world-class athletes and returning them to play in top performance shape.
Sports Medicine must include a variety of health and athletic professionals and physical therapists often play a significant role in providing that connectivity, said Cavanaugh. Current Concepts gives HSS the opportunity to share the most up-to-date and current trends in sports medicine, whether its knee ligament repair, shoulder surgery or evaluation diagnostic tools.
CURRENT CONCEPTS IN SPORTS MEDICINE:
DATE: Friday, April 19, 2013, and Saturday, April 20, 2013
TIMES: 8 a.m. 6 p.m. on Friday, April 19 7:20 a.m. 4:20 p.m. on Saturday, April 20
LOCATION: Hospital for Special Surgery Richard L. Menschel Education Center, 2nd Floor 535 East 70th Street New York
DETAILS: The seventh annual conference includes: Live surgery, and presentations and discussions that will recognize the most current approaches for managing and treating anterior shoulder instability; Discuss the principles of treatment progressions for the postsurgical hip arthroscopy population; Review surgical intervention for articular cartilage injuries and the implication for post-operative rehabilitation; Identify common injuries in the long-distance swimmer, runner and cyclist; and describe an evidence-based approach to rehabilitation strategies related to ACL prevention programs, weight training for the adolescent athlete and developing flexibility.
See the rest here:
Sports Medicine Experts Address Injuries in Throwing and Multisport Athletes
Medical advances made during wars will help doctors treat the injured victims of the Boston bombings.
Christian Science Monitor /Getty Images
The bombs that made Boston look like a combat zone have also brought battlefield medicine to their civilian victims. A decade of wars in Iraq and Afghanistan has sharpened skills and scalpels, leading to dramatic advances that are now being used to treat the 13 amputees and nearly a dozen other patients still fighting to keep damaged limbs.
"The only field or occupation that benefits from war is medicine," said Dr. David Cifu, rehabilitation medicine chief at the Veterans Health Administration.
Nearly 2,000 American troops have lost a leg, arm, foot or hand in Iraq or Afghanistan, and their sacrifices have led to advances in the immediate and long-term care of survivors, as well in the quality of prosthetics that are now so good that surgeons often chose them over trying to save a badly mangled leg.
Tourniquets, shunned during the Vietnam War, made a comeback in Iraq as medical personnel learned to use them properly and studies proved that they saved lives. In Boston, as on the battlefield, they did just that by preventing people from bleeding to death.
Military doctors learned and passed on to their civilian counterparts a surgical strategy of a minimal initial operation to stabilize the patient, followed by more definitive ones days later, an approach that experience showed offered the best chance to preserve tissue from large and complex leg wounds.
At the same time, wartime demand for prosthetics has led to new innovations such as sophisticated computerized knees that work better than a badly damaged leg ever would again.
"This is a clear case where all of the expertise that was gained by prosthetic manufacturers was gained from the wars. It's astonishing how well they function and the things people can do with these prostheses," said Dr. Michael Yaffe, a trauma surgeon at Beth Israel Deaconess Medical Center in Boston.
The hospital has performed amputations on three blast victims so far. A few other patients there may yet need them. Yaffe is a lieutenant colonel in the Army Reserves, and many other doctors treating Boston blast victims also have had military training.
Originally posted here:
War medicine being used to help injured Boston bombing victims
Medical advances made during wars will help doctors treat the injured victims of the Boston bombings.
Christian Science Monitor /Getty Images
The bombs that made Boston look like a combat zone have also brought battlefield medicine to their civilian victims. A decade of wars in Iraq and Afghanistan has sharpened skills and scalpels, leading to dramatic advances that are now being used to treat the 13 amputees and nearly a dozen other patients still fighting to keep damaged limbs.
"The only field or occupation that benefits from war is medicine," said Dr. David Cifu, rehabilitation medicine chief at the Veterans Health Administration.
Nearly 2,000 American troops have lost a leg, arm, foot or hand in Iraq or Afghanistan, and their sacrifices have led to advances in the immediate and long-term care of survivors, as well in the quality of prosthetics that are now so good that surgeons often chose them over trying to save a badly mangled leg.
Tourniquets, shunned during the Vietnam War, made a comeback in Iraq as medical personnel learned to use them properly and studies proved that they saved lives. In Boston, as on the battlefield, they did just that by preventing people from bleeding to death.
Military doctors learned and passed on to their civilian counterparts a surgical strategy of a minimal initial operation to stabilize the patient, followed by more definitive ones days later, an approach that experience showed offered the best chance to preserve tissue from large and complex leg wounds.
At the same time, wartime demand for prosthetics has led to new innovations such as sophisticated computerized knees that work better than a badly damaged leg ever would again.
"This is a clear case where all of the expertise that was gained by prosthetic manufacturers was gained from the wars. It's astonishing how well they function and the things people can do with these prostheses," said Dr. Michael Yaffe, a trauma surgeon at Beth Israel Deaconess Medical Center in Boston.
The hospital has performed amputations on three blast victims so far. A few other patients there may yet need them. Yaffe is a lieutenant colonel in the Army Reserves, and many other doctors treating Boston blast victims also have had military training.
Original post:
An injured person is helped on the sidewalk near the Boston Marathon finish line following an explosion in Boston, Monday, April 15, 2013.AP Photo/MetroWest Daily News, Ken McGagh
The bombs that made Boston look like a combat zone have also brought battlefield medicine to their civilian victims. A decade of wars in Iraq and Afghanistan has sharpened skills and scalpels, leading to dramatic advances that are now being used to treat the 13 amputees and nearly a dozen other patients still fighting to keep damaged limbs after Monday's attack.
"The only field or occupation that benefits from war is medicine," said Dr. David Cifu, rehabilitation medicine chief at the Veterans Health Administration.
Nearly 2,000 U.S. troops have lost a leg, arm, foot or hand in Iraq or Afghanistan, and their sacrifices have led to advances in the immediate and long-term care of survivors, as well as in the quality of prosthetics that are now so good that surgeons often choose them over trying to save a badly mangled leg.
Military doctors passed on to their civilian counterparts a surgical strategy of a minimal initial operation to stabilize the patient, followed by more definitive ones days later, an approach that offered the best chance to preserve tissue from large and complex leg wounds.
At the same time, wartime demand for prosthetics has led to new innovations such as sophisticated computerized knees that work better than a badly damaged leg ever would again.
"This is a clear case where all of the expertise that was gained by prosthetic manufacturers was gained from the wars. It's astonishing how well they function and the things people can do with these prostheses," said Dr. Michael Yaffe, a trauma surgeon at Beth Israel Deaconess Medical Center in Boston.
The hospital has performed amputations on three blast victims so far. A few other patients there may yet need them. Yaffe is a lieutenant colonel in the Army Reserves, and many other doctors treating Boston blast victims also have had military training.
The military partnered with the American Academy of Orthopaedic Surgeons to train doctors throughout the United States on advances learned from the wars, said Dr. Kevin Kirk, an Army lieutenant colonel who is chief orthopedic surgeon at San Antonio Military Medical Center.
Help, too, has come from Israel, which for decades has dealt with the aftermath of Palestinian bombs, like the ones in Boston, often laden with nails, ball bearings and other metals.
Read the rest here:
The bombs that made Boston look like a combat zone have also brought battlefield medicine to their civilian victims. A decade of wars in Iraq and Afghanistan has sharpened skills and scalpels, leading to dramatic advances that are now being used to treat the 13 amputees and nearly a dozen other patients still fighting to keep damaged limbs after Monday's attack.
"The only field or occupation that benefits from war is medicine," said Dr. David Cifu, rehabilitation medicine chief at the Veterans Health Administration.
Nearly 2,000 U.S. troops have lost a leg, arm, foot or hand in Iraq or Afghanistan, and their sacrifices have led to advances in the immediate and long-term care of survivors, as well as in the quality of prosthetics that are now so good that surgeons often choose them over trying to save a badly mangled leg.
Tourniquets, shunned during the Vietnam War, made a comeback in Iraq as medical personnel learned to use them properly and studies proved that they saved lives. In Boston, as on the battlefield, they did just that by preventing people from bleeding to death.
Military doctors passed on to their civilian counterparts a surgical strategy of a minimal initial operation to stabilize the patient, followed by more definitive ones days later, an approach that offered the best chance to preserve tissue from large and complex leg wounds.
At the same time, wartime demand for prosthetics has led to new innovations such as sophisticated computerized knees that work better than a badly damaged leg ever would again.
"This is a clear case where all of the expertise that was gained by prosthetic manufacturers was gained from the wars. It's astonishing how well they function and the things people can do with these prostheses," said Dr. Michael Yaffe, a trauma surgeon at Beth Israel Deaconess Medical Center in Boston.
The hospital has performed amputations on three blast victims so far. A few other patients there may yet need them. Yaffe is a lieutenant colonel in the Army Reserves, and many other doctors treating Boston blast victims also have had military training.
The military partnered with the American Academy of Orthopaedic Surgeons to train doctors throughout the United States on advances learned from the wars, said Dr. Kevin Kirk, an Army lieutenant colonel who is chief orthopedic surgeon at San Antonio Military Medical Center.
Help, too, has come from Israel, which for decades has dealt with the aftermath of Palestinian bombs, like the ones in Boston, often laden with nails, ball bearings and other metals.
Original post:
DUBLIN--(BUSINESS WIRE)--
Research and Markets has announced the addition of the "Chinese Patent Medicine Industry Report, 2012-2015" report to their offering.
In recent years, China's Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Over the same period, the total profit maintained a CAGR of 26.6%, and the gross margin remained higher than the average level of the overall pharmaceutical industry.
In succession to the Opinions on Promoting the Development of Traditional Chinese Medicine Services and Trade, the Twelfth Five-Year Plan on the Development of Traditional Chinese Medicine and other favorable policies, the new National Essential Drugs List published in March 2013 increased the number of Chinese patent medicine from 102 in 2009 to 203, and the proportion in total quantity from 33% to 39%. As a result, China's Chinese patent medicine market demand is expected to grow rapidly in the next five years.
Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases, musculoskeletal diseases and digestive system diseases are top five categories of Chinese patent medicine for hospitals in China. The Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases occupies the largest market share, which remained at around 37% in 2006-2012.
Key Topics Covered
1. Overview of Chinese Patent Medicine
1.1 Definition and Features
1.2 Classification
2. Operating Environment for Chinese Patent Medicine Industry
Excerpt from:
Research and Markets: Chinese Patent Medicine Industry Report, 2012-2015
Personalised Medicine in sarcoma: molecular subtypes drive treatment
Half of sarcomas show molecular alterations and more than 10 molecular subtypes now allow to be treated with a more personalised or targeted approach. Jean-Y...
By: ESMOchannel
See the original post:
Personalised Medicine in sarcoma: molecular subtypes drive treatment - Video
Brave and True - Savannah Outen - Music is Medicine Collaboration
Download this song here: http://bit.ly/15iP8BU Music is Medicine: http://www.musicismed.org - Physical copy of my ORIGINAL ALBUM - http://bit.ly/10vxW7H - Fo...
By: Savannah7448
Read more:
Brave and True - Savannah Outen - Music is Medicine Collaboration - Video
CHAPEL HILL, N.C., April 16, 2013 /PRNewswire/ --TSI Healthcare, a national leader in the sales and support of customized healthcare information technology, celebrates Carolina Orthopaedic and Sports Medicine Center's selection as winners of the annual "Circle of Excellence Award" in the Practice Management System category. Established in 2009, the award recognizes practices that have positioned themselves as leaders in Healthcare IT and champions of improved patient care through the use of Electronic Health Records and Practice Management systems. The award focuses on key indicators that measure efficiency, regulatory compliance, and delivery of quality care through the use of technology.
Practice Manager Chad Ghorley from Carolina Orthopaedic and Sports Medicine Center of Gastonia, NC commented, "As physicians strive for better care, the use of technology is key. Health IT results in improved efficiency, increased revenues, while allowing us to focus on our patients. Partnering with a vendor that provides the necessary resources and customer service is equally as important. The "Circle of Excellence" award is an example of TSI Healthcare's dedication to our practice. It allows our group to benchmark our system use, encouraging staff to master basic functionality and try new features. Ultimately, using a top-notch Practice Management system helps us drive improved patient satisfaction through efficient business workflows."
TSI Healthcare's President and CEO, David Dickson Jr. adds, "Carolina Orthopaedic and Sports Medicine Center is a true leader in the healthcare community. In fact, our survey found key attributes that show exceptional commitment to improving the patient experience. Their team has worked diligently to attain maximum use of their systems and serve as an outstanding example for other practices. We are proud to work alongside groups like Carolina Orthopaedic and Sports Medicine Center, who are seeking to bring healthcare to the twenty-first century."
About Carolina Orthopaedic and Sports Medicine Center
Carolina Orthopaedic & Sports Medicine Center (COSMC) is proud of its long heritage of providing expert orthopaedic care in the Piedmont area, dating back to the original North Carolina Orthopaedic Hospital which was also located in Gastonia, NC. COSMC's team of highly-trained and talented orthopaedic surgeons, a physiatrist and physician assistants offers quality care and strives to provide exceptional customer service to the patients and family members whom they serve. For more information about COSMC, visit the practice website at http://www.carolinaorthopaedic.com.
About TSI Healthcare
TSI Healthcare, Inc. was founded in 1997 and empowers physicians to improve care, increase efficiency and maximize profitability through the successful implementation and utilization of the NextGen integrated EPM and EHR Systems. Each of TSI's solutions are customized, managed and designed to serve the unique needs of the client and the individual practice needs. TSI Healthcare's support and service teams include NextGen Certified Professionals, clinical experts, former practice administrators, and EHR and Practice Management Consultants. For more information, visit http://www.tsihealthcare.com or call 800-354-4205.
Contact: Christian Mibelli TSI Healthcare 800-354-4205 101 Europa Drive, Suite 200 Chapel Hill, NC 27517
See the original post:
Eight new addiction medicine fellowship programs have been accredited by the American Board of Addiction Medicine (ABAM) Foundation, bringing the total number of programs to 18, Newswise reports.
Doctors who complete one of these fellowships are eligible to sit for the ABAM exam to become certified in addiction medicine. There are 47 addiction medicine fellowship slots available, although some slots are not yet funded, according to the article.
These new fellowships will help insure that trained addiction medicine physicians join other addiction professionals in the interdisciplinary care of patients with addictive disorders, said Jeffrey H. Samet, MD, MA, MPH, President of ABAM and the ABAM Foundation Board of Directors. This clinical training, coupled with passage of our rigorous examination, will help to provide evidence-based addiction treatment to those who need it.
The new fellowship programs are located at the Betty Ford Center/Eisenhower Medical Center, Rancho Mirage, California; Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Hartford Hospital, Hartford, Connecticut; St. Joseph Mercy Hospital Ann Arbor, Ypsilanti, Michigan; St. Pauls Hospital, Vancouver, British Columbia, Canada; St. Vincent Charity Medical Center, Cleveland, Ohio; Stanford Hospital and Clinics, Stanford, California; and Yale-New Haven Hospital, New Haven, Connecticut.
Our workforce projections suggest that, by 2020, we will need 50 addiction medicine fellowship training programs with 200 physician slots, said Richard Blondell, MD, Chair of the Foundations Training and Accreditation Committee. One of the main obstacles to establishing these programs is funding.
Demand for addiction treatment will expand as the Affordable Care Act adds millions of new patients to the system. Addiction medicine courses are rarely offered in medical school, the article notes.
Here is the original post:
Zheng Tian Wan is unregulated but available in the UK Medicine contains herb known as Queen of Poisons Could be toxic for the heart and nervous system Experts urge anyone who has taken herb to visit GP
By Rachel Reilly
PUBLISHED: 11:40 EST, 17 April 2013 | UPDATED: 11:40 EST, 17 April 2013
The plant remedy contains aconite a herb once dubbed the 'Queen of Poisons'
A herbal medicine used by alternative practitioners to treat migraines could be fatal.
Zheng Tian Wan is unregulated but is available in the UK, and it has been linked to serious health complications and death, health authorities say.
The plant remedy contains aconite a herb once dubbed the Queen of Poisons by the ancient Greeks - and could be toxic for the heart and nervous system.
The ingredient is on a UK list of restricted herbal ingredients and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued a statement warning against using the product.
The MHRA said the issue came to their attention after a herbal practitioner supplied a patient the unlicensed migraine pills, which have not been tested for safety and quality.
The agency said it has previously received three reports of suspected side effects to aconite.
The rest is here:
Popular Chinese medicine used for migraines could be FATAL, warn watchdogs
SEATTLE--(BUSINESS WIRE)--
Two new reports issuing in Science Translational Medicine (STM) today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The results demonstrate that better predictors of breast cancer progression than those currently available can be rapidly evolved by running open Big Data Challenges such as The Sage Bionetworks/DREAM Breast Cancer Prognosis Challenge (BCC).
In breast cancer, a key undertaking is determining those patients whose disease is most likely to progress rapidly and therefore tailor the best course of treatment for them. Currently oncologists are using gene-expression based assays such as MammaPrint and Oncotype Dx, that are based on 10 year old science, and both do better with breast cancer risk prediction than models based only on clinical data.
Dr. Stephen Friend, the Founder of Sage Bionetworks and one of the organizers of the BCC reflects, Ten years ago, members of our research group used gene expression profiling to build one of the first breast cancer predictors. Mammaprint and Oncotype Dx were developed off of that but further improvement seems to have stalled. We wondered if running a Challenge like BCC would motivate lots of different groups to tackle this problem, some working collaboratively, and if that might be more fruitful than the current 'go it alone' single researcher approach.
To push the envelope on all the innovations that could be incorporated into the BCC, Sage partnered with the DREAM Project, a visionary distributed systems biology group that has run 24 successful open computational challenges over the last five years.
DREAMs founder and leader, Dr. Gustavo Stolovitzky saw the BCC as an opportunity to, refocus our efforts to create a collaborative research environment that fosters a complementary way of doing science, which accelerates the pace of discovery with the goal of contributing to a faster reduction of suffering due to disease. This seems to me like an ethical imperative.
The goal of the BCC was to build a computational model that accurately predicts breast cancer survival. To do this, participants of the Challenge used genomic and clinical information from 2000 women diagnosed with breast cancer (theMETABRIC data set). They accessed this data on Synapse, Sage Bionetworks open compute platform for data sharing and analysis: Google donated cloud-based standardized virtual machines that each participant used to train their models against the data. Individual participants and/or teams submitted their computational models to Synapse as open source code made viewable to all: their models were assessed against a hidden dataset and their scores were reported on a real-time leaderboard. The combination of immediate feedback and code-sharing allowed participants to improve their leaderboard ranking by adjusting their own models or by borrowing the code of others to forge new models.
Throughout the July-October 2012 model-training phase, a crowd of 350 players from 35 countries across the globe joined the Challenge and submitted a total of 1700 computational models for scoring. The winning model was determined by scoring the predictive accuracy of players models against a newly generated data set: for this, the Avon Foundation For Women funded the generation of gene expression and copy number data as well as collection of corresponding clinical information from 180 breast cancer patients. Finally, the BCC organizers recognized that the basic science community might be most energized to participate if the Challenge prize were not money but the invitation to publish an article about the winning model in a top tier journal. The editors of STM saw the unique opportunity to run their own experiment on how to structure the peer-review process for competition-based crowdsourcing studies such as the BCC. Todays issue of STM features not only the winners article (the BCC Challenge prize) and a report from the BCC organizers on the Challenges conception, execution and insights -- STM also chose to highlight the BCC with an Editorial Summary and an iconic cover of Rosie the Riveter, intended to symbolize the power of women and their data to transform health.
Quipped Challenge participant Richard Savage (MRC Fellow in Biostatistics at the University of Warwick) on the prospect of winning the opportunity to publish in STM, This is huge and a genuinely new way to do some great science. I really think the organizers are onto something with this.
Go here to see the original:
CHEVY CHASE, Md.--(BUSINESS WIRE)--
Precision for Medicine, Inc. (Precision) today announced that Vicki Seyfert-Margolis PhD has joined the company as Chief of Science and Strategy. Dr. Seyfert-Margolis joins Precision from the U.S. Food and Drug Administration (FDA) where she served as Senior Advisor, Regulatory Science and Innovation, reporting to the Commissioner. In that role, Dr. Seyfert-Margolis was responsible for spearheading the FDAs regulatory science and personalized medicine initiative, the agencys strategy for promoting innovative approaches in drug development, strategies for big data and scientific computing, as well as policies and guidance for companion diagnostics and co-development. Prior to the FDA, Dr. Seyfert-Margolis was Chief Science Officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.
We are proud to have Vicki join the Precision leadership team, said Mark P. Clein, President. She brings a rare combination of scientific credibility, industry expertise, and an intimate understanding of the factors that are driving modern regulatory decision-making, innovation, and policy. She will play a critical role in guiding our scientific strategy and providing insight and support for our clients.
Precision for Medicine shares my vision for the future of health care one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development, said Dr. Seyfert-Margolis. The patient becomes central throughout the product lifecycle. Real world information will be as important as sequencing in developing targeted medications and identifying the best treatment paradigms. I am excited to help build what is truly a next generation service company to support the innovators of tomorrows medical products.
About Precision for Medicine
Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient centric solutions from discovery through commercialization. The company is headquartered in Chevy Chase, MD with offices in Gaithersburg, MD, Frederick, MD and Cambridge, MA. For more information about Precision, visitwww.precisionformedicine.com.
Read this article:
Newswise The American Board of Addiction Medicine (ABAM) Foundation today announced the accreditation of eight addiction medicine fellowship programs, bringing the total number of accredited programs to 18. Physicians who complete an ABAM Foundation fellowship are eligible to sit for the ABAM certification examination in order to become board certified in addiction medicine.
The fellowship programs, which are modeled on the Foundations national guidelines, Program Requirements for Graduate Medical Education in Addiction Medicine, are based at leading medical institutions across the U.S. and Canada. Accreditation of these new programs means that there are now 47 addiction medicine fellowship slots available, although some slots are not yet funded.
These new fellowships will help ensure that trained addiction medicine physicians join other addiction professionals in the interdisciplinary care of patients with addictive disorders, said Jeffrey H. Samet, MD, MA, MPH, President, ABAM and ABAM Foundation Board of Directors, and Professor of Medicine at Boston University School of Medicine. This clinical training coupled with passage of our rigorous examination will help to provide evidence-based addiction treatment to those who need it.
The new fellowship programs are located at the Betty Ford Center/Eisenhower Medical Center, Rancho Mirage, CA; Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Rushford, A Hartford HealthCare Partner, Middletown, CT; St. Joseph Mercy Hospital Ann Arbor, Ypsilanti, MI; St. Pauls Hospital, Vancouver, British Columbia, Canada; St. Vincent Charity Medical Center, Cleveland, OH; Stanford Hospital and Clinics, Stanford, CA; and Yale-New Haven Hospital, New Haven, CT (see end of release for more detail).
We greatly value medical education and this ABAM Foundation accreditation acknowledges this, said James W. Golden, MD, Program Director, Betty Ford Center Addiction Medicine Fellowship Program. We take this very seriously and are ready to step up to the plate to do the vital work necessary to educate physicians on the prevention and treatment of addictive disorders and medical and psychiatric complications of addiction. This accreditation is a validation that the Betty Ford Center has the expertise in both faculty and staff to accomplish this.
The new fellowship programs join those located at Saint Lukes and Roosevelt Hospitals, Addiction Institute of New York; Boston University Medical Center; University of Cincinnati College of Medicine; Geisinger Health System at Marworth, Waverly, PA; University of Minnesota Medical School; New York University School of Medicine; The University at Buffalo (SUNY) School of Medicine; University of Florida; University of Maryland School of Medicine; and the University of Wisconsin.
Our workforce projections suggest that, by 2020, we will need 50 addiction medicine fellowship training programs with 200 physician slots, said Richard Blondell, MD, Chair of the Foundations Training and Accreditation Committee, and Professor of Family Medicine at the University of Buffalo School of Medicine. One of the main obstacles to establishing these programs is funding.
The ABAM Foundation-accredited fellowship programs provide subspecialty training, which is offered to physicians already trained in a specialty such as internal medicine, family medicine, pediatrics, psychiatry, emergency medicine, surgery, preventive medicine, or obstetrics and gynecology.
The American Board of Psychiatry and Neurology offers its own fellowships in the psychiatry subspecialty of addiction psychiatry. There are 45 addiction psychiatry fellowship programs in the U.S.
The new training programs have been established at a time of increasing promise for addiction treatment, and increased need for trained treatment providers. Recent scientific discoveries have confirmed that addiction is a chronic disease of the brain caused by biological and developmental factors, with unique vulnerabilities and pathology, and a predictable course, if not interrupted by effective treatment. An increasing number of medically based addiction treatments have recently become available. Expanded coverage and demand for addiction medicine physicians will increase, as 30 million formerly uninsured Americans become covered under the Patient Protection and Affordable Care Act.
Visit link:
Eight Addiction Medicine Fellowship Programs Accredited by ABAM Foundation
WASHINGTON, April 17, 2013 /PRNewswire/ -- The Regenerative Medicine Annual Report, released today at the Alliance for Regenerative Medicine's (ARM) first annual Regen Med Investor Day, provides an overview of the tremendous growth and progress in the regenerative medicine (RM) sector during the past year. The 70-page report includes in-depth information on RM products currently available, details on late stage clinical trials and financial information such as fundraisings and market performance. The Report also outlines the elements of a US national strategy to support this sector.
With more than 100 RM products on the market, and an estimated 2,500 ongoing clinical trials worldwide, the field is making a significant impact on the treatment of chronic and life threatening diseases. Products currently available or in clinical development encompass diverse therapeutic areas such as oncology, cardiovascular and ocular diseases, wound healing, autoimmune disorders and spinal cord injuries. There are now more than 700 companies worldwide with a RM focus, ranging from divisions of multinational corporations to small organizations. Revenue from RM products on the market in 2012 exceeded $1billion and more than another $1 billion in combined public and private funding was invested into the sector.
"Unlike many therapeutics currently available that are designed to address symptoms of disease or delay disease progression, RM products have the potential to cure or significantly change the course of disease," said Geoff MacKay, Chairman of ARM and President and CEO of Organogenesis Inc. "We are thrilled with the progress that has been made in the field and are dedicated to continuing our work with regulatory agencies, policy makers and payers to further define strategies to streamline and support the commercialization of additional RM products."
The second Regenerative Medicine Annual Report is available online at http://www.alliancerm.org and in a limited print edition. Below are highlights of the report:
"While significant clinical progress has been made in progressing life-changing regenerative medicine therapies toward commercialization, there are still many regulatory, reimbursement and financial challenges to address before the field can reach its full potential," said Michael Werner, Executive Director of ARM. "Many countries have national programs in place for regenerative medicine, and it is critical that the United States develops a national strategy to support our U.S-based, life science-focused public and private companies and research institutions."
About the Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.
Media Contact: Michelle Linn Linnden Communications Phone: 774-696-3803
See the original post here:
Palack University - Faculty of Medicine and Dentistry
By: MedicineInOlomouc
Follow this link:
Palacký University - Faculty of Medicine and Dentistry - Video
Married To Medicine #39;s Mariah Huq dishes on Career, Cast-Mates, and Future
Note: This is a sponsored video http://www.wrugmedia.com WRUG MEDIA GROUP Spoke with Married to Medicine star, creator, and co-producer Mariah Huq about her career,...
By: wrugradio
More here:
Married To Medicine's Mariah Huq dishes on Career, Cast-Mates, and Future - Video
Married to Medicine: Fighting Over Mama Drama
Toya Bush-Harris confronts Mariah Huq about Mariah #39;s mother #39;s attitude. Watch Married to Medicine every Sunday at 9/8c. http://www.bravotv.com/married-to-med...
By: VideoByBravo
View original post here:
Homestead Honey Hour April 12 2013 Herbal Medicine!
By: TheMrsVolfie
Original post: